Basis for detection of stenosis using venous administration of microbubbles during myocardial contrast echocardiography: bolus or continuous infusion?  by Wei, Kevin et al.
EXPERIMENTAL STUDIES
Basis for Detection of Stenosis Using Venous Administration of
Microbubbles During Myocardial Contrast Echocardiography:
Bolus or Continuous Infusion?
KEVIN WEI, MD, FACC, ANANDA R. JAYAWEERA, PHD, SOROOSH FIROOZAN, MD,
ANDRE LINKA, MD, DANNY M. SKYBA, PHD, SANJIV KAUL, MD, FACC
Charlottesville, Virginia
Objectives. This study sought to determine the basis of detec-
tion of stenosis by myocardial contrast echocardiography using
venous administration of microbubbles and to define the relative
merits of bolus injection versus continuous infusion.
Background. The degree of video intensity (VI) disparity in
myocardial beds supplied by stenosed and normal coronary
arteries can be used to quantify stenosis severity after venous
administration of microbubbles. However, the comparative merits
of administering microbubbles as a bolus injection or continuous
infusion has not been studied.
Methods. Coronary stenoses of varying severity were created in
either the left anterior descending or the left circumflex coronary
artery in 18 dogs. Imagent US (AF0150) was given as a bolus
injection in 10 dogs (Group I) and as both a bolus injection and
a continuous infusion in 8 dogs (Group II). For bolus injections,
peak VI was derived from time–intensity plots. During continuous
infusion, microbubble velocity and microvascular cross-sectional
area were derived from pulsing interval versus VI plots. Myocar-
dial blood flow (MBF) was determined using radiolabeled micro-
spheres.
Results. During hyperemia, VI ratios from the stenosed versus
normal beds correlated with radiolabeled microsphere–derived
MBF ratios from those beds for both bolus injections (r 5 0.81)
and continuous infusion (r 5 0.79). The basis for detection of
stenosis common to both techniques was the decrease in myocar-
dial blood volume distal to the stenosis during hyperemia. The
advantage of continuous infusion over bolus injection was the
abolition of posterior wall attenuation and the ability to quantify
MBF.
Conclusions. Both bolus injection and continuous infusion
provide quantitative assessment of relative stenosis severity.
Compared with bolus injection, continuous infusion also allows
quantification of MBF and data acquisition without attenuation of
any myocardial bed.
(J Am Coll Cardiol 1998;32:252–60)
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The most frequent indication for myocardial perfusion imaging
is for localizing coronary stenoses and estimate their severity
(1). Myocardial contrast echocardiography (MCE) is a new
method of assessing myocardial perfusion in which micro-
bubbles are injected into the vascular system, and their pres-
ence in the myocardium is detected with ultrasound (1).
Microbubbles capable of opacifying the myocardium from a
venous injection have recently become available (2–5). When
combined with intermittent harmonic imaging, they result in
adequate myocardial opacification (2–5).
We previously showed (2) that during exogenously induced
coronary hyperemia, the relative background-subtracted video
intensity (VI) from different myocardial beds during a bolus
intravenous injection of microbubbles reflects the relative
myocardial blood flow (MBF) to these regions. We postulated
(2) that the ability of VI to reflect relative MBF resulted from
the closely coupled changes in MBF and myocardial blood
volume (MBV) during hyperemia. More recently, we showed
(6) that MBF can be quantified during a continuous intra-
venous infusion of microbubbles by measuring changes in
mean myocardial microbubble velocity and microvascular
cross-sectional area (CSA) (or MBV). The purpose of the
present study was to determine the basis of detection of
stenosis using venous administration of microbubbles during
MCE and to compare the relative merits and drawbacks of
continuous infusion versus bolus injection.
From the Cardiovascular Division, University of Virginia School of Medi-
cine, Charlottesville, Virginia. This study was supported in part by a grant
R01-HL48890 from the National Heart, Lung, and Blood Institute, National
Institutes of Health, Bethesda, Maryland and by a grant from Alliance Pharma-
ceutical Corporation, San Diego, California. Hewlett Packard Corporation,
Andover, Massachusetts provided an equipment grant, and the radiolabeled
microspheres were provided by Dupont-Merck, North Billerica, Massachusetts.
Dr. Wei was the recipient of a Junior Personnel Research Fellowship from the
Heart and Stroke Foundation of Canada, Ottawa, Ontario, Canada, and Dr.
Firoozan was the recipient of a Junior Research Fellowship from the British
Heart Foundation, London, England, United Kingdom. Dr. Linka was supported
by the Ciba-Geigy Jubila¨ums-Stiftung, Basel, Switzerland and the Theodor und
Ida Herzog-Egli Stiftung, Zurich, Switzerland. Dr. Skyba is supported by a
postdoctoral fellowship Grant F32-HL095410 from the National Institutes of
Health. This work was presented in part at the 46th Annual Scientific Session of
the American College of Cardiology, March 1997, Anaheim, California.
Manuscript received October 21, 1997; revised manuscript received March
13, 1998, accepted April 8, 1998.
Address for correspondence: Dr. Sanjiv Kaul, Cardiovascular Division, Box
158, University of Virginia Medical Center, Charlottesville, Virginia 22908.
E-mail: sk@virginia.edu.
JACC Vol. 32, No. 1
July 1998:252–60
252
©1998 by the American College of Cardiology 0735-1097/98/$19.00
Published by Elsevier Science Inc. PII S0735-1097(98)00212-5
Methods
Animal preparation. The study protocol was approved by
the animal research committee at the University of Virginia
and conformed to the “Position of the American Heart
Association on Research Animals Use” adopted by the Asso-
ciation in November 1984. A total of 18 dogs were anesthetized
with 30 mg/kg21 body weight of sodium pentobarbital (Ab-
bott), intubated and ventilated with a respirator pump (model
607, Harvard Apparatus). Catheters (7F) were placed in both
femoral arteries for withdrawal of reference samples during
radiolabeled microsphere injections and in both femoral veins
for administration of fluids, drugs and microbubbles, respec-
tively. The tip of a 7F pulmonary artery balloon-tipped flota-
tion catheter (model MPA-372T, Millar Instruments) was
positioned in the main pulmonary artery for measurement of
cardiac output.
A left lateral thoracotomy was performed, and the heart
was suspended in a pericardial cradle. A 7F catheter was
placed in the left atrium for pressure measurements and the
injection of radiolabeled microspheres. A similar catheter was
placed in the ascending aorta for the measurement of aortic
pressure. Ultrasound time of flight flow probes (series SB,
Transonics) were placed around the proximal portions of the
left anterior descending (LAD) and left circumflex (LCx)
coronary arteries and were connected to a digital flowmeter
(model T206, Transonics). A 20-guage Teflon catheter (Cri-
tikon) was introduced into one of the arteries through a side
branch, and a custom-designed screw occluder was placed
around the vessel to produce coronary stenoses of varying
severity.
Hemodynamic variables. All catheters were connected to
fluid-filled pressure transducers that, like the flowmeter, were
connected to a multichannel recorder (model ES 2000, Gould
Electronics). Coronary blood flow (CBF) and pressures were
acquired digitally at 200 Hz on an 80386-based personal
computer. The signals were displayed on-line using Labtech
Notebook (Laboratory Technologies). The severity of the
stenosis was judged by the mean pressure gradient between the
aorta and the distal coronary artery. Coronary driving pressure
was calculated by subtracting the mean right atrial pressure
from the mean distal coronary pressure.
MCE imaging. Imaging was performed in harmonic mode
(transmit 2 MHz, receive 4 MHz) using a prototype Sonos 2500
system (Hewlett-Packard) (6). The ultrasound transducer was
fixed in position with a custom-designed clamp, and a saline
bath served as an acoustic interface between the transducer
and the heart. The maximal dynamic range (60 dB) was used.
The transmit power, focus, overall gain and image depth were
held constant for each experiment.
A second-generation microbubble, Imagent US (AFO150,
Alliance Pharmaceuticals), was used that consists of
surfactant-coated microbubbles containing perfluorohexane
and nitrogen (5). These microbubbles have a mean diameter of
5 mm and a mean concentration of 5z108zml21. For the bolus
injections, a single trigger was used to acquire one end-systolic
image from each cardiac cycle (2–4). For continuous infusions,
dual triggering was used. The first trigger was used for
microbubble destruction and the second to acquire images in
end-systole (6). The interval between these triggers (pulsing
interval [PI]) was increased from 150 ms to 12 s to allow
progressively greater bubble replenishment of the ultrasound
beam elevation (6). Up to eight end-systolic images were
acquired at each PI.
MCE images were analyzed off-line, as previously described
(7). For the bolus injections, end-systolic images from just
before contrast injection until its disappearance from the
myocardium were aligned. For continuous infusions, five im-
ages acquired at baseline and at each PI were selected and
aligned. Large transmural regions of interest were defined over
the LAD and LCx beds in any one image, and the VI was
automatically measured from the same regions in all images.
The average VI from four to five frames before the
appearance of microbubbles in the myocardium was consid-
ered to represent background. For bolus injections, time–
intensity plots were generated from the background-subtracted
VI and fit to a gamma-variate function: y 5 Ate2at, where A
Abbreviations and Acronyms
CBF 5 coronary blood flow
CBV 5 coronary blood volume
CSA 5 cross-sectional area
MBF 5 myocardial blood flow
MBV 5 myocardial blood volume
MCE 5 myocardial contrast echocardiography (echocardiographic)
LAD 5 left anterior descending coronary artery
LCx 5 left circumflex coronary artery
VI 5 video intensity
PI 5 pulsing interval
Table 1. Hemodynamic, Myocardial Blood Flow and Myocardial















2 6 2 10 6 3 23 6 6 , 0.001
Mean CBF (ml/min) 37 6 14 35 6 17 34 6 16 0.59




5 6 4† 18 6 7† 33 6 10† , 0.001
Mean CBF (ml/min) 97 6 46† 57 6 20† 51 6 21† 0.002
Mean MBF (ml/min per g)‡ 1.9 6 0.5 1.4 6 0.5 1.3 6 0.3 0.03
Peak VI* 0.9 6 0.2† 0.7 6 0.3 0.6 6 0.2† 0.001
*Normalized to the nonstenosed bed. †p , 0.001 versus baseline (No
Stenosis). ‡Data not obtained during baseline (No Stenosis). Data presented are
mean value 6 SD. CBF 5 coronary blood flow; MBF 5 myocardial blood flow;
VI 5 video intensity.
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is a scaling factor; t is time; and a is proportional to the transit
rate of the tracer. Peak VI was calculated from the equation
A/ae (7). For continuous infusions, background-subtracted PI
versus VI plots were generated and fitted to an exponential
function: y 5 A(1 2 e2bt), where y is the VI at a PI t; A is the
plateau VI representing microvascular CSA (or MBV); and b
is the rate constant reflecting the rate of rise of VI (or the
mean microbubble velocity) (6). In addition to the above
analyses, color-coding was also performed to visually enhance
the presence of perfusion mismatch (7). Shades of red, pro-
gressing to hues of orange, yellow and then white, represent
incremental myocardial opacification. The left ventricular cav-
ity was masked out.
Radiolabeled microsphere MBF measurement. MBF was
measured using left atrial injections of ;2z106 11-mm radiola-
beled microspheres (Dupont Medical Products) suspended in
4.0 ml of 0.9% saline and 0.01% Tween-80 (8). Arterial
reference blood samples were collected using a constant rate
withdrawal pump (model 944, Harvard Apparatus). At the end
of the experiment, the short-axis slice of the left ventricle
corresponding to the MCE image was cut into 16 wedge-
shaped pieces, and each piece was further divided into epicar-
dial, midcardial and endocardial segments. The tissue and
blood samples were counted in a well counter with a mul-
tichannel analyzer (model 1282, LKB Wallac). Corrections
were made for activity spilling from one energy window to
another (8).
MBF to each epicardial, midcardial and endocardial seg-
ment was calculated from the equation Qm5(CmzQr)/Cr,
where Qm is blood flow to the myocardial segment (ml/min);
Cm is tissue count; Qr is rate of arterial sample withdrawal
(ml/min); and Cr is arterial reference sample count (8). Trans-
mural MBF (ml/min per g) to each of the 16 wedge-shaped
pieces was calculated as the quotient of the summed flows to
the individual segments within that piece and their combined
weight. MBF to each bed (defined by monastral blue dye
injection [see later]) was then calculated by averaging the
transmural MBF in the central 50% to 75% of the pieces in
each bed.
Experimental protocol. In Group I dogs (n 5 10), a
baseline stage and up to five separate stenosis stages were
performed. These stenoses were non–flow limiting at rest, and
Figure 1. Color-coded images and corre-
sponding time–intensity plots (fitted to a
gamma-variate function) in a Group I dog
during hyperemia. At baseline (A), there is
no difference in VI between the LAD and
LCx beds. In the presence of a mild stenosis
(transstenotic pressure gradient 14 mm Hg),
VI in the LAD bed decreased compared
with that in the LCx bed (B). The decrease
was even greater (C) in the presence of a
moderate stenosis (transstenotic pressure
gradient 22 mm Hg). Open squares 5 LAD
bed; solid squares 5 LCx bed.
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their severity was defined by the pressure gradient across them.
At each stage, hemodynamic data were acquired, and MCE
was performed at baseline by injecting 0.2 to 0.8 ml of AFO150
(mean 0.5 6 0.2) into the femoral vein, followed by a 5-ml
0.9% NaCl flush. The dose was determined at the beginning of
each experiment and was adjusted to produce mild myocardial
opacification with minimal posterior wall attenuation. It was
then held constant for the duration of the study. MCE was
performed after radiolabeled microspheres were injected, only
during hyperemia and before and after placement of each
stenosis. Hyperemia was induced by venous infusion of
0.4 mg/kg per min of WRC-0470 (Discovery Therapeutics), a
selective adenosine A2a receptor agonist (2,3).
In Group II dogs (n 5 8), hemodynamic, radiolabeled
microsphere and MCE data were obtained before and after
placement of two non–flow-limiting stenoses of varying sever-
ity. All data were obtained at baseline and during hyperemia.
Microbubbles were administered at each stage, both as an
intravenous bolus injection and as a continuous infusion. For
continuous infusions, a solution consisting of 4 ml of AFO150
in 50 ml of 0.9% saline was administered through the femoral
vein at a rate of 2 ml/min, which allowed adequate myocardial
opacification and no posterior wall attenuation.
At the end of the experiment, the artery undergoing
stenosis was occluded at the site of the screw occluder, and
monastral blue dye (Sigma Chemical) was injected into it
through the distal catheter. This procedure allowed delinea-
tion of the LAD or LCx bed at the short-axis MCE imaging
plane. The dog was then killed with an overdose of pentobar-
bital, and the heart was removed from the chest cavity. The
heart was cut into five short-axis slices, and the slice corre-
sponding to the MCE imaging plane was processed for radio-
labeled microsphere analysis.
Statistical methods. Comparisons between more than two
values were made using two-way repeated measures analysis of
variance, and group interactions between levels of stenosis and
presence or absence of hyperemia were ascertained. When
analysis of variance showed significance (p , 0.05, two-tailed),
multiple comparisons between groups was performed using a
paired Student t test with the Bonferroni correction. Linear
regression analysis (least-squares fit) was performed for deriv-
ing correlations.
Results
Group I dogs. Table 1 depicts data from the stenosed bed
at baseline in the 10 Group I dogs. The severity of each
stenosis was defined by the pressure gradient across it:
,5 mm Hg (none); 5 to 14 mm Hg (mild); and $15 mm Hg
(moderate). The epicardial CBF remained unchanged at dif-
ferent levels of stenosis, indicating that all stenoses were
non–flow limiting at baseline. No differences were noted in the
normalized background-subtracted peak VI. Table 1 also
depicts data from the stenosed bed during hyperemia in Group
I dogs. The mean transstenotic gradient increased, whereas the
epicardial CBF and radiolabeled microsphere–derived MBF
decreased with increasing levels of stenosis. These values were
significantly different from baseline. The normalized peak VI
was significantly lower with increasing levels of stenosis, and
for moderate stenosis was significantly less than baseline
values. No significant interactions were noted between stenosis
severity and the presence or absence of hyperemia.
Figure 1 illustrates color-coded images and their corre-
sponding time–intensity curves obtained before stenosis place-
ment and in the presence of LAD stenoses of varying severity
during hyperemia. In all images, some attenuation of the
posterior wall is seen because of the presence of microbubbles
in the left ventricular cavity. Nonetheless, much of the LCx bed
Figure 2. Relation between MBF ratio (x axis) and VI ratio (y axis)
obtained from the stenosed versus the normal bed in Group I dogs
during hyperemia.
Table 2. Hemodynamic, Myocardial Blood Flow and Myocardial












2 6 2 12 6 3 21 6 6 , 0.001
Mean CBF (ml/min) 39 6 24 32 6 21 31 6 11 0.90
Mean MBF (ml/min per g) 1.1 6 0.4 0.9 6 0.3 1.0 6 0.1 0.60
A* 1.1 6 0.2 0.9 6 0.3 0.9 6 0.2 0.30
b* 1.1 6 0.2 1.0 6 0.2 0.9 6 0.1 0.10




3 6 2 22 6 6† 25 6 6 , 0.001
Mean CBF (ml/min) 89 6 48‡ 47 6 27† 38 6 13† 0.03
Mean MBF (ml/min per g) 2.7 6 1.3‡ 1.4 6 0.6‡ 1.5 6 0.5‡ 0.03
A* 1.1 6 0.2 0.9 6 0.2 0.7 6 0.3 0.005
b* 1.1 6 0.3 0.5 6 0.3‡ 0.6 6 0.2‡ 0.001
Azb* 1.2 6 0.3 0.4 6 0.2‡ 0.3 6 0.1‡ , 0.001
*Normalized to nonstenotic bed. †p 5 0.002, ‡p 5 0.001 versus baseline (No
Stenosis). Data presented are mean value 6 SD. A 5 plateau video intensity
representing microvascular cross-sectional area (or myocardial blood volume);
b 5 rate constant reflecting rate of rise of video intensity; other abbreviations as
in Table 1.
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is visible in the lateral portion of the myocardium. Before
stenosis placement, the degree of contrast enhancement (and
therefore the color) is similar in the two beds. After stenoses
placement, the color of the LAD bed takes on more hues of
orange and red, denoting lesser degrees of contrast enhance-
ment than that of the LCx, which still retains hues of yellow
and white. Good correlation was found between the
background-subtracted peak VI and the radiolabeled micro-
sphere–derived MBF ratios from the stenosed versus normal
bed during hyperemia, when data from all 10 dogs were pooled
(Fig. 2).
Group II dogs. Table 2 depicts data from the stenosed bed
at baseline in the eight Group II dogs; stenosis severity was
classified as in the Group I dogs. No changes were noted in
epicardial CBF, radiolabeled microsphere– derived MBF,
background-subtracted plateau VI, mean microbubble velocity
or MCE-derived MBF with increasing levels of stenosis, which,
as stated earlier, were not flow limiting at rest.
Table 2 also depicts data from the stenosed bed during
hyperemia in the Group II dogs. The transstenotic gradient
increased significantly with increasing degrees of stenosis
during hyperemia, whereas mean epicardial CBF decreased.
The values for no and mild stenosis were significantly different
from baseline values. Radiolabeled microsphere–derived MBF
decreased progressively with increasing levels of stenosis, but
was always higher than baseline values. Background-subtracted
plateau VI, mean microbubble velocity and MCE-derived
MBF also decreased with increasing levels of stenosis during
hyperemia, and the two latter values were significantly lower
than baseline values. No significant interactions were noted
between the level of stenosis and the presence or absence of
hyperemia.
The top panels in Figure 3 illustrate color-coded images
and corresponding time–intensity curves from bolus injections
during hyperemia in the absence and presence of a LAD
stenosis. It is evident that peak VI in the LAD bed decreases
during hyperemia in the presence of a stenosis. The top panels
in Figure 4 illustrate data in the same dog during continuous
infusions. Similar to Figure 3, the severity and extent of relative
hypoperfusion in the stenosed bed during hyperemia are
clearly seen. However, there is no posterior wall attenuation.
Similar to bolus injection (Fig. 3), the VI during continuous
infusion (Fig. 4) is lower during stenosis. In addition, mean
microbubble velocity and MCE-derived MBF are also lower.
Figure 5A illustrates a linear relation between the MCE-
derived MBF and radiolabeled microsphere–derived MBF
ratios from the stenosed versus the normal bed. The relation is
linear, with a slope close to the line of identity. A linear
relation was also noted between the peak and plateau VI ratios
from the stenosed versus normal beds during bolus injection
and continuous infusion, respectively (Fig. 5B). Thus, similar
information on MBV was afforded by both methods of micro-
bubble administration.
The PI at which the greatest disparity in VI between the two
Figure 3. Color-coded images and corre-
sponding time–intensity plots (fitted to a
gamma-variate function) in a Group II dog
receiving a bolus injection of contrast during
hyperemia. At baseline (A), there is no
difference in VI between the LAD and LCx
beds. In the presence of a mild stenosis
(pressure gradient 13 mm Hg), VI in the
LAD bed is less than that in the LCx bed
(B). Arrows indicate the region in the LCx
bed from which the time–intensity curves
were derived; other symbols as in Figure 1.
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beds is seen during continuous infusions can also be selected
from the PI versus VI plots (Fig. 6). Panels A to C in Figure 6
depict three contrast-enhanced color-coded images obtained
at different PIs during continuous infusion in a dog with a very
mild stenosis. Panel D in the same image illustrates the PI at
which these images were selected. Only in panel B is the VI
disparity most clearly seen. This image can be selected from
the sequence of images to optimize the display of both the
severity of stenosis and the extent of relative hypoperfusion.
Hemodynamic results. No effects were noted on left atrial,
right atrial and aortic pressures or on cardiac output during
repeated injections of AFO150 in Group I and II dogs (total
dose ;20 and 35 ml, respectively) (Table 3).
Discussion
Basis for detection of stenosis during venous administra-
tion of microbubbles. The entire coronary system (epicardial
conduit arteries, arterioles, capillaries, venules and veins)
contains ;12 ml of blood/100 g of left ventricular mass (total
CBV), one-third of which is in the capillaries (9). The blood
present in the left ventricular myocardial vessels is the MBV
and measures ;4.5 ml/100 g. When a mild to moderate
stenosis (,85% lumen diameter narrowing) is present on an
epicardial coronary artery, baseline MBF is maintained at
normal levels by vasodilation of arterioles distal to the stenosis
Figure 4. Color-coded images and the corre-
sponding VI versus PI curves at baseline (A)
and in the presence of a LAD stenosis (B)
during continuous infusion in the same Group
II dog as in Figure 3. The images correspond
to the point in the curves where maximal
contrast disparity between the stenosed and
normal beds was seen. Symbols as in Figure 3.
Figure 5. A, Relation between radiolabeled microsphere-derived MBF
ratio (x axis) and MCE-derived MBF (AzB ratio) from the stenosed
versus normal bed in all Group II dogs during hyperemia (y axis). B,
Relation between peak VI ratio during bolus injection (x axis) and
plateau VI ratio during continuous infusion (y axis) from the stenosed
versus normal bed in all Group II dogs.
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(10). The magnitude of this response is related to the severity
of stenosis. It follows, therefore, that the measurement of CBV
at rest can provide an estimate of stenosis severity. We and
others have previously shown that CBV increases with increas-
ing levels of stenosis (11,12). These results were obtained from
the measurement of mean transit rates after direct bolus
injections of microbubbles into the coronary artery, which
reflect changes in the entire CBV (13).
In the present study, we did not observe any change in
myocardial VI at baseline despite the placement of mild to
moderate stenoses, which indicates that in the presence of
non–flow-limiting stenoses at rest, MBV remains constant
despite increases in total CBV. This phenomenon occurs
because autoregulation does not principally involve the vessels
within the myocardium, the majority of which (.90%) are
capillaries (9). In comparison to the situation at rest, a
decrease in MBV was noted for increasing levels of stenosis
during hyperemia.
Based on our experience with bolus injections, we previ-
ously postulated that MBV may actually decrease distal to the
stenosis during hyperemia (2,14). However, with bolus injec-
tions we could not determine whether the lower VI in the
stenosed bed was actually due to an absolute decrease in MBV
distal to the stenosis or simply relative to a greater MBV
increase in the normal bed. In the present study, since the
concentration of microbubbles in the blood remained constant
during continuous infusions, a decline in myocardial VI distal
to a stenosis indicates an actual decline in MBV. The mecha-
nism for the decrease in MBV is not known but indicates a
reduction in capillary density distal to the stenosis in the
presence of hyperemia. This finding forms the basis for the
detection and determination of the physiologic relevance of a
coronary stenosis with MCE, irrespective of the method of
contrast injection.
Bolus or continuous infusion? To produce myocardial
opacification from a venous injection, we previously (2,3) used
large doses of microbubbles, which resulted in severe attenu-
ation of the posterior half of the heart. It was therefore
necessary to wait for the microbubble concentration in the left
ventricular cavity to decrease before VI measurements in the
Figure 6. Color-coded images during continu-
ous infusion in a Group II dog (A to C) with a
mild stenosis at three different PIs. The image
showing the maximal VI difference between the
stenosed (LAD) and normal (LCx) beds (B)
was selected from the VI versus PI curve (D).
This image best represents the presence and
severity of stenosis. Symbols as in Figure 1.
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LAD or LCx beds could be made (2,3). Consequently, our
measurements were not necessarily performed when maximal
VI disparity was noted between the two beds. In the present
study, we adjusted our doses for bolus injections to levels
where adequate myocardial opacification could be produced
with minimal posterior wall attenuation. As can be appreciated
from Figures 1 and 3, myocardial VI measurements could be
made simultaneously from both beds during peak contrast
effect, despite the presence of posterior wall attenuation.
The difference between bolus and continuous infusion is
that in the former, the concentration of microbubbles in blood
changes with time, whereas in the latter, it remains stable after
equilibration is reached. In either case, the relative VI between
two myocardial beds reflects the relative MBV fractions of
those beds (2), provided that the microbubble concentration is
low enough to be in the linear range of its relation with VI (15).
The obvious advantage of bolus injection is that it can be
performed in a rapid manner and can provide an immediate
qualitative assessment of stenosis severity during hyperemia.
However, we believe that continuous infusion is a better
approach for detection of stenosis for several reasons:
1. During continuous infusion, the dose of microbubbles
can be customized to individual patients. There is great
variability in the degree of tissue attenuation in different
patients, and an individualized dose is more appropriate to
provide meaningful results.
2. Posterior wall attenuation can be largely abolished with
continuous infusions by titrating the rate of infusion, some-
thing almost impossible to achieve consistently with a bolus
injection. Shadowing of the posterior wall has so far precluded
the use of parasternal views during bolus injections. These
views are important for the comprehensive evaluation of
patients with coronary artery disease.
3. A constant infusion provides the time and leisure to
interrogate each myocardial segment in detail, using even
unorthodox views, without having to worry about missing a
segment because of the limited duration of myocardial opaci-
fication afforded by a bolus injection.
4. The same person (sonographer or physician) can start
the infusion, adjust the rate of administration and perform the
entire examination. Another person is not required for re-
peated microbubble administration, as is needed with bolus
injections.
5. Both microbubble velocity and MBV can be assessed
with this approach. If myocardial VI can be calibrated to left
ventricular VI, and if the beam elevation is known, then the
product of microbubble velocity and MBV can provide a
quantitative assessment of MBF (6).
Conclusions. In the present study, we evaluated two ap-
proaches for detection of coronary stenosis from venous
administration of microbubbles: bolus injection and continu-
ous infusion. We determined that the basis for detection of
stenosis during hyperemia common to both methods is a
decrease in MBV. We also discussed the merits and potential
disadvantages of both approaches. Studies in patients need to
be performed to determine which approach is most suitable in
the clinical setting.
We are grateful to Norman C. Goodman, BS for technical assistance and to
Robert D. Abbott, PhD for advice regarding statistical methods.
References
1. Lindner JR, Kaul S. Myocardial perfusion imaging using tracers other than
radioisotopes and detectors other than gamma cameras. In: Beller GA,
Zaret BL, editors. Nuclear Cardiology: State-of-the-art and Future Direc-
tions. 2nd ed. Mosby Year Book. In press.
2. Firschke C, Lindner JR, Wei K, Skyba D, Goodman NC, Kaul S. Myocardial
perfusion imaging in the setting of coronary artery stenosis and acute
myocardial infarction using venous injection of FS-069, a second generation
echocardiographic contrast agent. Circulation 1997;96:959–67.
3. Lindner JR, Firschke C, Wei K, Goodman NC, Skyba DM, Kaul S.
Myocardial perfusion characteristics and hemodynamic profile of MRX-115,
a venous echocardiographic contrast agent, during acute myocardial infarc-
tion. J Am Soc Echocardiogr 1998;11:36–46.
4. Porter TR, Xie F. Transient myocardial contrast after initial exposure to
diagnostic ultrasound pressures with minute doses of intravenously injected
microbubbles: Demonstration and potential mechanisms. Circulation 1995;
92:2391–5.
5. Mulvaugh SL, Foley DA, Aeschbacher BC, Klarich KK, Seward JB. Second
harmonic imaging of an intravenously administered echocardiographic con-
trast agent. Visualization of coronary arteries and measurement of coronary
blood flow reserve. J Am Coll Cardiol 1996;27:1519–25.
6. Wei K, Firoozan S, Jayaweera AR, Linka A, Skyba DM, Kaul S. Quantifi-
cation of myocardial blood flow with ultrasound-induced destruction of
microbubbles administered as a continuous infusion. Circulation 1998;97:
473–83.
7. Jayaweera AR, Sklenar J, Kaul S. Quantification of images obtained during
myocardial contrast echocardiography. Echocardiography 1994;11:385–96.
8. Heyman MA, Payne BD, Hoffman JI, Rudolf AM. Blood flow measurements
with radionuclide-labeled particles. Prog Cardiovasc Dis 1977;20:52–79.
9. Kassab GS, Lin DH, Fung YB. Morphometry of pig coronary venous system.
Am J Physiol 1994;267:H2100–13.
10. Gould KL, Lipscomb K. Effects on coronary stenoses on coronary flow
reserve and resistance. Am J Cardiol 1974;34:48–55.
11. Lindner JR, Skyba DM, Goodman NC, Jayaweera AR, Kaul S. Changes in
myocardial blood volume with graded coronary stenosis: an experimental
evaluation using myocardial contrast echocardiography. Am J Physiol 1007;
272:H567–75.









Group I (n 5 10)
Baseline 8 6 6 12 6 3 87 6 12 3 6 1
Injection 1 8 6 4 15 6 4 86 6 9 3 6 1
Injection 2 8 6 5 15 6 2 77 6 7 3 6 1
Injection 3 7 6 3 15 6 5 79 6 10 4 6 1
Injection 4 8 6 2 16 6 3 77 6 8 3 6 1
Group II (n 5 8)
Baseline 7 6 1 13 6 3 102 6 12 —
Infusion 1 7 6 1 14 6 3 96 6 10 —
Infusion 2 7 6 1 13 6 2 90 6 16 —
*No interstage differences noted. Data presented are mean value 6 SD.
AoP 5 mean aortic pressure; CO 5 cardiac output; LAP 5 left atrial pressure;
RAP 5 right atrial pressure.
259JACC Vol. 32, No. 1 WEI ET AL.
July 1998:252–60 CONTINUOUS INFUSION VS. BOLUS FOR STENOSIS DETECTION
12. Wu CC, Feldman MD, Mills JD, Fisher D, Jafar MZ, Villanueva FS.
Myocardial contrast echocardiography can be used to quantify intramyocar-
dial blood volume: new insights into structural mechanisms of coronary
autoregulation. Circulation 1997;96:1004–11.
13. Kaul S, Jayaweera AR. Coronary and myocardial blood volumes: noninva-
sive tools to assess the coronary microcirculation? Circulation 1997;96:719–
24.
14. Ismail S, Jayaweera AR, Camarano G, Gimple LW, Powers ER, Kaul S.
Relation between air-filled albumin microbubble and red blood cell rheology
in the human myocardium: influence of echocardiographic systems and chest
wall attenuation. Circulation 1996;94:445–51.
15. Jayaweera AR, Ismail S, Kaul S. Attenuation deforms time-intensity curves
during contrast echocardiography: implications for the assessment of transit
rates. J Am Soc Echocardiogr 1994;7:590–7.
260 WEI ET AL. JACC Vol. 32, No. 1
CONTINUOUS INFUSION VS. BOLUS FOR STENOSIS DETECTION July 1998:252–60
